News

Cancer survivors have higher medical costs


 

FROM MORBIDITY AND MORTALITY WEEKLY REPORT

Average annual medical expenses for male cancer survivors were more than double those of men with no history of cancer in 2008-2011, while expenditures for female cancer survivors were 64% higher than those of women without a history of cancer, the Centers for Disease Control and Prevention reported.

A male cancer survivor had a mean annual medical expenditure of $8,091 from 2008 to 2011, along with $3,719 in lost productivity from employment disability, missed work days, and lost household productivity. A man without a history of cancer, by comparison, had an annual medical expenditure of $3,904 and a total productivity loss of $2,260, according to the CDC investigators (MMWR 2014;63:505-10).

For a female cancer survivor, annual medical expenditures totaled $8,412, with $4,033 in lost productivity in 2008-2011. In that same time period, a woman with no history of cancer had medical costs of $5,119 and productivity losses of $2,703, the CDC said.

The report was based on data from the 2008-2011 Medical Expenditure Panel Survey (6,722 cancer survivors and 86,865 with no history) and the 2011 MEPS Experiences with Cancer Survivorship Survey (1,202 cancer survivors).

rfranki@frontlinemedcom.com

Recommended Reading

Invasive cancer incidence highest in black men
MDedge ObGyn
First ASCO survivor care guidelines tackle fatigue, anxiety/depression, neuropathy
MDedge ObGyn
AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics
MDedge ObGyn
VIDEO: HPV testing predicted to displace most Pap smears
MDedge ObGyn
CDC: Policy changes could prevent 100,000 deaths a year
MDedge ObGyn
First SEER analysis including HER2 subtype is reported
MDedge ObGyn
Obesity increased breast cancer mortality only in premenopausal women
MDedge ObGyn
Breast cancer fear contributes to prophylactic mastectomy rate
MDedge ObGyn
VIDEO: Goserelin helps dodge ovarian failure in HR-negative breast cancer
MDedge ObGyn
VIDEO: Less frequent zoledronic acid is safe, retains efficacy
MDedge ObGyn